Regulator Name,Regulator Type,Regulator Subtype,Regulator HGNC Symbol,Regulator Database,Regulator ID,Regulator Compartment,Regulator Compartment ID,Regulated Name,Regulated Type,Regulated Subtype,Regulated HGNC Symbol,Regulated Database,Regulated ID,Regulated Compartment,Regulated Compartment ID,Sign,Connection Type,Mechanism,Site,Cell Line,Cell Type,Tissue Type,Organism,Unnamed: 0,Score,Source,Statements,Paper IDs,Evidence Score,Match Score,Kind Score,Epistemic Value,Total Score
early growth response protein 1,protein,,egr1,uniprot,q92579,nucleus,go:0005634,pten,protein,,pten,uniprot,q00533,plasma membrane,go:0005886,positive,d,binds,pten promoter region,,,,human,['29'],nan,nan,"in addition to gene mutations, complete or partial loss of pten protein expression may impact pten's tumor suppression ability. the regulation of pten's functions and signaling pathway is shown in figure 2. positive regulators of pten gene expression include early growth response protein 1, peroxisome proliferator-activated receptor γ (pparγ) and p53, which have been shown to directly bind to the pten promoter region [27–29]. early growth response protein 1, which regulates pten expression during the initial steps of apoptosis, has been shown to directly upregulate the expression of pten in non–small cell lung cancer. pparγ is a ligand-activated transcription factor with anti-inflammatory and anti-tumor effects. the activation of its selective ligand, rosiglitazone, leads to the binding of pparγ at two pten promoter sites, ppar response element 1 and ppar response element 2, thus upregulating pten and inhibiting pi3k activity. negative regulators of pten gene expression include mitogen-activated protein kinase kinase-4, transforming growth factor beta (tgf-β), nuclear factor of kappa light polypeptide gene enhancer in b-cells (nf-κb), igf-1, the transcriptional cofactor c-jun proto-oncogene, and the b-cell-specific moloney murine leukemia virus insertion site 1 (bmi1) proto-oncogene, which have been shown to suppress pten expression in several cancer models [30–32]. research found that igf-1 could affect cell proliferation and invasion by suppressing pten's phosphorylation. in pancreatic cancers, tgf-β significantly suppresses pten protein levels concomitant with the activation of akt through transcriptional reduction of pten mrna–induced growth promotion. c-jun negatively regulates the expression of pten by binding to the activator protein 1 site of the pten promoter, resulting in the concomitant activation of the akt pathway. pten transcription is also directly repressed by the leukemia-associated factor ecotropic virus integration site 1 protein in the hematopoietic system [33].",pmc4712330,1,100,40,1,140
cd5,protein,,cd5,uniprot,p00417,plasma membrane,go:0005886,erk,protein,,,uniprot,,plasma membrane,go:0005886,positive,d,phosphorylation,,,b-cell,,mouse,['35'],nan,nan,"our data showed that cd5-ck2 signaling regulates both sustained and acute activation of erk, thus having an impact on positive selection and thymocyte survival. analysis of erk phosphorylation by imagestream further confirmed and provided more statistical power to the data obtained with standard flow cytometry (fig 8 and s4 fig.). interestingly, in contrast to adult mice, the absence of cd5-ck2 signaling in neonatal mice, led to reduced basal levels of p-erk. however, both adult and neonatal thymocytes from cd5-δck2bd mice showed enhanced phosphorylation of erk in response to cd3, compared to their wt counterparts (figs 6 and 7). although, phosphorylation of perk by ck2 is shown to promote its entry into the nucleus [30], we found that this was not altered in cd5-δck2bd thymocytes. this would indicate that ck2 activated by cd5 engagement does not participate directly in erk translocation. additionally, we analyzed jnk and p38 phosphorylation, as these mapk have also been involved in thymocyte selection (reviewed in ([1]). similar to erk, enhanced phosphorylation of jnk, but not of p38, was detected in newborn cd5-δck2bd thymocytes in response to cd3 stimulation. although p38 has recently been shown to promote thymocyte survival and can be activated downstream cd5 [47], our data suggest that cd5 does not mediate p38 dependent signals during thymocyte development.",pmc5193405,1,100,40,1,140
mek1,protein,,mapk8,uniprot,p12872,cytoplasm,go:0005739,erk,protein,,mapk3,uniprot,q05252,cytoplasm,go:0005739,negative,d,phosphorylation,t292,,,,,['54'],nan,nan,"we have recently reported that mek1 is essential for the regulation of the timing and strength of erk signaling. by phosphorylating the t292 site in the proline-rich region of mek1, erk exerts negative feedback control on mek1/mek2 dimers. if mek1 is absent, this control is disabled, leading to increased erk signaling (catalanotti et al., 2009).",pmc3625979,1,100,40,1,140
itk,protein,,itk,uniprot,q05232,plasma membrane,go:0005886,foxp3,protein,,fosl1,uniprot,p61479,plasma membrane,go:0005886,positive,d,phosphorylation,,,naive,,mouse,['2'],nan,nan,"to determine whether the increased differentiation into foxp3+-expressing cells was a more global property of itk−/− cd4+ t cells, we evaluated the differentiation of naive cells under treg cell conditions. when naive cd4+ cells were stimulated with standard concentrations of anti-cd3 (1 µg/ml) in the presence of wt apcs plus il-2 and tgf-β1, a significantly higher percentage of itk-deficient cells became foxp3+ than cells from wt mice (65.4 ± 2.9% vs. 40.1 ± 1.6% in wt cells; fig. 2 a). accordingly, naive itk−/− cd4+ t cells differentiated under these itreg cell–inducing conditions exhibited higher amounts of foxp3 mrna than wt itreg cells (fig. 2 b). similar observations were obtained when naive cd4+ t cells from 5cc7 transgenic mice were differentiated in the presence of treg cell–inducing cytokines (fig. 2 c). naive gfp−cd4+ t cells sorted from itk−/− foxp3gfp mice also gave rise to higher percentages of foxp3+ itreg cells compared with wt mice (fig. 2 d), arguing that these observations were not the result of outgrowth of foxp3+ cells present before culturing. thus, naive cd4+ t cells deficient in itk give rise to increased foxp3+ cells in vitro.",pmc3949578,1,100,40,1,140
tcr,other,,,fplx,tcr,plasma membrane,go:0005886,akt,protein,,akt1,uniprot,q05780,cytoplasm,go:0005634,negative,d,phosphorylation,,wt cd4+ t cells,b-cell,,vein,['9'],nan,nan,"since the homeostasis of t cells involves constant stimulation of the tcr by self-ligands27, we asked whether the tcr signal could stimulate akt degradation and whether this signalling event was regulated by tbk1. to avoid the homeostatic effect of tbk1 deficiency, we employed wt cd4+ t cells. indeed, the stimulation of the wt cd4+ t cells with anti-cd3 and anti-cd28 led to the gradual loss of akt (fig. 5e). moreover, a small-molecule inhibitor of tbk1, mrt67307 (ref. 28), efficiently inhibited the akt degradation (fig. 5e). we next employed a transient transfection model to see whether overexpressed tbk1 was able to induce akt degradation. indeed, the expression of tbk1, but not its catalytically inactive mutant (k38a), caused drastic loss of endogenous akt, which was blocked by a proteasome inhibitor, mg132 (fig. 5f). tbk1 also induced the proteolytic degradation of exogenously expressed akt but did not affect the co-transfected control protein gfp (supplementary fig. 6f).",pmc4302769,1,100,40,1,140
tcr,other,,,fplx,tcr,plasma membrane,go:0005886,foxp3,protein,,foxp3,uniprot,q9bx78,nucleus,go:0005634,positive,d,phosphorylation,,,b-cell,,vein,['14'],nan,nan,"despite an extensive literature on the function of t reg cells in a variety of contexts, little is known about the signaling mechanisms involved in their differentiation and maintenance, or in the regulation of foxp3 expression. several papers document defects in signaling molecules downstream of the tcr or of co-stimulatory receptors that affect the differentiation of both the cd4 single-positive (sp) tconv population and the t reg lineage (references 16–19; for review see reference 20). on the other hand, the identification of signaling factors specifically involved in t reg cell differentiation has remained elusive. differentiation of thymic t reg cells, like that of conventional cd4sp thymocytes, is highly dependent on signals emanating from the tcr (3, 20). the repertoire of tcrs displayed by t reg cells is distinct from that of tconv cells (21–24) and appears to be enriched for self-reactive specificities (22, 25). it has been proposed that t reg cell differentiation relies on tcrs with high affinity for mhc–self-peptide complexes (26–28), although this preference is not necessarily imparted by all high-affinity tcr interactions (29–31). thus, although common signaling pathways coordinate the differentiation of tconv and t reg cells, it is not clear whether quantitative or qualitative differences account for differentiation into the two lineages.",pmc2275380,1,100,40,1,140
pak1,protein,,pak1,uniprot,q92570,cytoskeleton,go:0005739,jnk,protein,,mapk8,uniprot,q92679,cytoskeleton,go:0005739,positive,d,phosphorylation,,,t-cell,,mouse,['46'],nan,nan,"in addition to this effect of pak1 on jnk activation, we previously described a role for a pak1/plcγ-1/bam32 complex in erk activation in both normal cd4+ t cells [7] and in cd4+ t cells isolated from lat-ki mice [5]. furthermore, genetic studies from both our laboratory [5, 6] and others [56] have shown a definitive role for erk signaling in lat-ki lymphoproliferative disease. these and other studies have revealed that there are multiple roads leading to erk activation depending on the signaling environment [57]. this study provides the first evidence that mir-155 modulates erk activation. paradoxically, mir-155 deletion delayed lat-ki lymphoproliferative disease despite causing an increase in erk activation. this effect is in contrast to other null mutants crossed to lat-ki mice (rasgrp1 and bam32), which decreased erk activation and decreased lymphoproliferative disease [5, 6]. we propose that pak1/jnk pathway-mediated apoptosis contributes more to the effect on lymphoproliferative disease than pak1/erk-mediated proliferation in dm t cells. both pak1 and jnk have been associated with cell death [58–60]. here we propose that mir-155, pak1 and jnk are part of a common pathway to apoptosis in t cells. incorporation of a single molecule into distinct pathways of proliferation and apoptosis could provide an elegant way of maintaining tissue homeostasis and preventing carcinogenesis. pak1 could provide such a function by mediating proliferation through pak1/erk action or apoptosis through pak1/jnk action.",pmc4487994,1,100,40,1,140
mek1,protein,,mapk8,uniprot,q96768,plasma membrane,go:0005886,akt,protein,,akt1,uniprot,q04772,plasma membrane,go:0005886,negative,d,inhibits,,t-lymphocyte,t-cell,,human,['55'],nan,nan,mek1 ablation deregulates akt activation and impairs activation-induced cell death,pmc3625979,1,100,40,1,140
pi3k,enzyme,,pi3k,uniprot,p00055,plasma membrane,go:0005886,akt,protein,,akt1,uniprot,q05209,plasma membrane,go:0005886,positive,d,phosphorylation,,,,,human,['25'],nan,nan,"only pi3k pan-inhibition switched off akt signaling, as demonstrated by the reduction or complete abrogation of both thr308 and ser473 p-akt levels. it has been previously reported that a limited pi3k activity is sufficient to support cell survival and proliferation and, consequently, complete pi3k inhibition is required to induce cell death [48]. consistent with that, in spite of changes in cell cycle progression, we observed a significant cell death induction almost exclusively after pi3k pan-inhibition, with the exception of loucy cells where the dual inhibition of p110γ/δ was also effective. importantly, we demonstrated that, at least in the case of zstk-474, the mechanisms involved in cell death are independent of caspase activity as a pan-caspase inhibitor did not reduce cell death.",pmc4496363,1,100,40,1,140
tcr,protein,,,uniprot,tcr,plasma membrane,go:0005886,mhcii,protein,,hla-dm,uniprot,p02094,endoplasmic reticulum,go:0005886,positive,d,binds,,5c.c7,t-cell,,mouse,['36'],nan,nan,"to explore the impact of tcr/pmhc affinity on peripheral foxp3 induction we used 5c.c7 t cells, which recognize a peptide from moth cytochrome c (mcc; 88–103) in the context of the mhcii molecule i-ek (davis et al., 1998). the 5c.c7 tcr is ideal for addressing this question because, in addition to the natural ligand mcc, a wide variety of related peptide ligands have been characterized for their tcr binding properties and in vitro activating potencies (reay et al., 1994; rabinowitz et al., 1996; wilson et al., 1999; li et al., 2004; krogsgaard et al., 2005). in addition to mcc, we assessed foxp3 induction by the weak agonist peptide 102s (reay et al., 1994; rabinowitz et al., 1996) and the superagonist k5 (krogsgaard et al., 2003, 2005; li et al., 2004), both of which contain mutations in tcr contact residues that result in a shorter or longer half-life of 5c.c7 tcr–pmhc interactions, respectively (corse et al., 2010; huppa et al., 2010). all of the peptides used in our study bind to mhc with comparable affinity (krogsgaard et al., 2003), which is essential to separate the influences of tcr ligand potency versus density of pmhc ligand upon t cell responses. to confirm the rank order of the peptides in our experimental setting, we stimulated 5c.c7 t cells with irradiated splenocytes and the indicated titration of peptide (fig. 1 a). as expected, at equivalent doses of peptide 102s induced less 5c.c7 proliferation and k5 more proliferation, relative to the natural ligand mcc. this difference in in vitro potency is apparent in the higher and lower ec50 values for 102s and k5, respectively (fig. 1 a).",pmc2916126,1,1,40,1,41
akt,protein,,akt1,uniprot,q04589,plasma membrane,go:0005886,t cells,cell,,,,t cells,,,positive,d,over-expression,,ot-1,t-cell,,mouse,['18'],nan,nan,"to examine if up-regulating akt activation could increase the activity of t cells in the presence of tumor, we transduced ot-1 cells with retroviruses encoding wild type akt (wtakt) or a constitutively active form of akt (myristoylated akt, myr-akt), and incubated the transduced ot-1 cells with b16-ova tumor cells. as shown in fig. 2a, when co-cultured with b16-ova, ot-1 cells transduced with either wtakt or myr-akt produced more ifn-γ than ot-1 cells transduced with control retroviruses. in the proliferation assay, ot-1 cells transduced with control retroviruses slowed proliferation on exposure to b16-ova tumor cells, whereas ot-1 cells transduced with either wtakt or myr-akt displayed higher proliferation rates when cultured alone, and further increased the percentage of proliferative populations when co-cultured with b16-ova (fig. 2b). together, these data demonstrates that over-expressing akt or myr-akt could increase the cytokine production and proliferation of tumor specific t cells in the presence of tumor.",pmc4550078,1,1,40,1,41
tcr,protein,other,tcr,uniprot,tcr,plasma membrane,go:0005886,foxp3+ t cells,protein,,,uniprot,,,,positive,d,recognize,,,,,vein,['38'],nan,nan,"we propose that a low density of a high-affinity tcr ligand is optimal to achieve the quantity and quality of stimulation required to induce a persistent population of foxp3+ t cells in vivo. in fact, considering that the foxp3− 5c.c7 t cells are deleted in these same conditions, and that injection of high doses of either mcc or 102s results in comparable loss of 5c.c7 t cells, specificity is most apparent in the survival of the foxp3+ 5c.c7 in response to small amounts of strong ligand. deletion and foxp3 induction are two proposed mechanisms of peripheral tolerance. however, how the strength and density of tcr ligand steers a self-reactive t cell between these fates is understudied. tcr repertoire analysis has suggested that t reg cells may recognize self-antigens with low avidity (hsieh et al., 2004). we suggest that low concentrations of specific self-pmhc complexes could contribute to peripheral foxp3 induction in response to self-antigens, even if the tcr–pmhc interaction is of a high affinity. in the case of more abundantly expressed self-pmhc complexes, our data suggest that deletion of the cognate t cells is a more likely mechanism of tolerance, regardless of the strength of the ligand and extent of foxp3 induction. it is interesting to speculate that there could be detrimental effects of maintaining t reg cells that recognize ubiquitous self-ligands, such as bystander suppression (masteller et al., 2005; tang and bluestone, 2008).",pmc2916126,1,1,40,1,41
foxp3,protein,,foxp3,uniprot,p06637,cytoplasm,go:0005739,5c.c7,cellpopulation,,,,,,,negative,d,binds,,5c.c7,t-cell,,human,['37'],nan,nan,"as expected, the dose for each peptide that triggered partial division of the responding 5c.c7 population was also the peak of foxp3 induction, based on the percentage of foxp3+ 5c.c7 t cells (0.3 µg mcc, 3 µg 102s, and 10 µg 102n; fig. 5, b and c). although the peak of foxp3 induction by 102s peptide in this more refined titration (3 µg) produced slightly more foxp3 induction than 10 µg, both doses still resulted in diminished numbers of foxp3+ 5c.c7 t cells compared with mcc. the numbers of 102s-induced foxp3+ 5c.c7 t cells were lower at day 8 (fig. 3) than at day 5 (fig. 5 d). thus, to gain more insight into the fate of cells stimulated by these strong and weak agonists, we quantitated the number of foxp3+ and foxp3− 5c.c7 t cells over time (fig. 6 and fig. s7).",pmc2916126,1,1,40,1,41
akt,protein,,vps30,uniprot,q05232,plasma membrane,go:0005886,epcam,protein,,epcam,uniprot,q05232,plasma membrane,go:0005886,positive,d,binds,,ot-1,t-cell,,tumor,['15'],nan,nan,we used ot-1 cells transduced with retroviruses encoding akt and human peripheral blood lymphocytes (pbls) transduced with retroviruses encoding both akt and a chimeric antigen receptor (car) specific for tumor antigen epcam to examine the effect of over-expressing akt on tumor specific t cells in tumor environment.,pmc4550078,1,1,40,1,41
mtor,protein,,p05587,uniprot,q9h2a1,cytoplasm,go:0005739,pak1,protein,,p05586,uniprot,q9h2a2,cytoplasm,go:0005739,positive,d,inhibition,,,,,,['42'],nan,nan,mtor inhibition activates pak1 signaling and a pak1-nucleated apoptotic pathway (jnk/foxo3/bim/caspase 9).,pmc4487994,1,1,40,1,41
pi3k,protein,,pik3ca,uniprot,q92077,plasma membrane,go:0005886,t-all cell line,cell,,,,,,,negative,d,inhibition,,t-all cell line,tumor,,human,['21'],nan,nan,inhibition of all the pi3k catalytic isoforms exerts the strongest effects on t-all cell line viability,pmc4496363,1,1,40,1,41
pten,protein,,pten,uniprot,q05284,plasma membrane,go:0005886,active site phosphorylation,posttranslationalmodification,,,uniprot,,,,positive,d,phosphorylation,"thr366, ser370, ser380, thr382, thr383, and ser385",,,,human,['30'],nan,nan,"post-translational modifications, such as active site phosphorylation, ubiquitination, oxidation, and acetylation, can also regulate pten activity [39]. in its inactivated state, pten is phosphorylated on a cluster of serine and threonine residues located on its c-terminal tail, leading to a “closed” pten state in which pten protein stability is maintained. as pten is being activated, dephosphorylation of its c-terminal tail opens its phosphatase domain, thereby increasing pten activity (figure 2). the phosphorylation of pten at specific residues of the c-terminal tail (thr366, ser370, ser380, thr382, thr383, and ser385) is associated with increased protein stability, whereas phosphorylation at other sites may decrease protein stability. although s370 and s385 have been identified as the major sites for pten phosphorylation, mutations of these residues have minimal effects on pten function, whereas mutations of s380, t382, and t383 can destabilize pten and increase its phosphatase activity, thereby enhancing pten's interaction with binding partners [40]. the “open” state of pten is more susceptible to ubiquitin-mediated proteasome degradation [13]. one recently identified e3 ligase of pten is neural precursor cell-expressed, developmentally down-regulated 4, e3 ubiquitin protein ligase 1 (nedd4-1), which mediates pten mono- and poly-ubiquitination [41] (figure 3). in cancer, the inhibition of nedd4-1, whose expression has been found to be inversely correlated with pten levels in bladder cancer, may upregulate pten levels [42]. two major conserved sites for pten are k13 and k289, and ubiquitination of these sites is indispensable for the nuclear-cytoplasmic shuttling of pten (figure 1).",pmc4712330,1,1,40,1,41
pten,protein,,pten,uniprot,q96357,cytoplasm,go:0005636,src,protein,proto-oncogene,src,uniprot,q96357,cytoplasm,go:0005636,positive,d,binds,,,b-cell,,human,['27'],nan,nan,"in addition to its lipid phosphatase function, pten also has lipid phosphatase–independent roles. pten has been shown to inhibit cell migration through its c2 domain, independent of pten's lipid phosphatase activity [18]. in breast cancer, pten deficiency has been shown to activate, in a manner dependent on its protein phosphatase activity, the src proto-oncogene, non-receptor tyrosine kinase (src), thereby conferring resistance to human epidermal growth factor receptor 2 inhibition [19]. furthermore, pten has been shown to directly bind to tumor protein 53 (p53), regulate its stability, and increase its transcription, thereby increasing p53 protein levels [20].",pmc4712330,1,1,40,1,41
akt,protein,,prk2,uniprot,p00044,plasma membrane,go:0005886,t cells,other,,,fplx,t cells,plasma membrane,go:0005886,positive,d,over-expression,,,t cell,,mouse,['19'],nan,nan,"the recent report by crompton et al. found that inhibition of akt enabled til a memory t cell signature with enhanced anti-tumor effect [23]. tils isolated for adoptive transfer normally undergo extensive expansion process in vitro, and display a terminally-differentiated phenotype with short telomere and diminished anti-tumor activity. in their study, akt inhibitor was added only in the expansion process, and they found that tils expanded with akt inhibition persisted longer and exerted better anti-tumor effects. comparing to their study, we used ot-1 t cells or pbls stimulated and expanded in vitro, which displayed a cd62l+ phenotype after the short expansion process (additional file 2: figure s2). akt is necessary to induce and sustain effector functions of t cell [18, 24], comparing to their study trying to enhance the persistence of t cells by inhibition of akt, we tried to enhance the effector functions of t cells by over-expressing akt, these two studies take different angles to manipulate t cells to enhance the anti-tumor efficacy, and are not contradictory to each other, and it’s worth further study to determine which means is superior to the other. in addition, in their work, tumor bearing mice were pretreated with total body irradiation, adjuvant vaccine, and il-2 in conjunction with cell therapy, these preparations could ameliorate tumor immunosuppression and enhance the anti-tumor effects of cell therapy, however, severe adverse effects have been reported. in contrast, we used adoptive cell therapy alone to treat tumor, and over-expressing akt could enable t cells to resist tumor immunosuppression, which is the major advantage of our strategy.",pmc4550078,1,1,40,1,41
akt,protein,,akt1,uniprot,p00437,plasma membrane,go:0005886,t cells,cell,,,,t cells,none,none,negative,d,inhibition,none,none,none,none,mouse,['17'],nan,nan,"to verify that akt activation in t cells is inhibited in tumor environment, t cells were isolated from ot-1 transgenic mice, stimulated with anti-cd3 and anti-cd28 antibodies, and then incubated with b16-ova tumor culture medium supernatant. 24 h later, the levels of phosphorylated akt were determined by western blot. as shown in fig. 1a, incubation with b16-ova culture supernatant inhibited akt phosphorylation, suggesting that akt activation in t cells is inhibited by tumor secreted factors. to examine akt activation state of t cells in tumor microenvironment in vivo, t cells were isolated from tumor draining lymph nodes (tdln) and distant lymph nodes (ln) of b16-ova tumor bearing mice, and akt phosphorylation was detected. as we expected, the phosphorylation of akt was down-regulated in tdln comparing to distant ln (fig. 1b).",pmc4550078,1,1,40,1,41
rag1,protein,,rag1,uniprot,q92579,cytoplasm,go:0005739,b6.sjl,mouse,,,uniprot,,,,negative,d,binds,,bone marrow,hematopoietic stem cell,bone marrow,mouse,['12'],nan,nan,"rag1-ko mice were subjected to lethal-dose (992 rads) irradiation and, 1 day later, were adoptively transferred with bone marrow cells harvested from the tibiae and femurs of the indicated mice. for mixed bone marrow transfers, an equal number (6.4 × 106) of bone marrows from the cd45.1+ b6.sjl and the cd45.2+ wt or tbk1-tko mice or from the gfp+ wt and the gfp–",pmc4302769,1,0.1,39,1,39.1
pd-l1,protein,,pdcd1l1,uniprot,q15237,plasma membrane,go:0005886,pbmc,cell,,,uniprot,,,go:0005886,positive,d,blockade,,,t cell,,human,['52'],nan,nan,"the pd-l1 blockade of pbmc from viremic hiv-infected individuals under stimulating conditions commonly led to increased reactivation of hiv ex vivo. the observed correlations between the fold change in virus p24 with the fold change in proliferating cd4 t cells, the percentage of treg cells as well as the negative correlations with the fold changes of cd4 and cd8 to treg cell ratios respectively, may indicate that an increase of treg cells in relation to cd8 t cells promotes virus expansion. these observations are compatible with the characteristics of hiv biology and stress the importance of applying antiviral treatment in addition to the pd-l1 blockade therapy.",pmc4669187,1,0.1,39,1,39.1
tbk1,protein,,tbk1,uniprot,q9hzs6,cytosol,go:0005731,carma1,protein,,carma1,uniprot,q9y2a7,cytosol,go:0005731,negative,d,binds,,b6,t-cell,,mouse,['11'],nan,nan,"the tbk1-flox mice were generated in b6 × 129 mixed genetic backgrounds44 and further backcrossed to the b6 mice for four generations. to generate t-cell-conditional tbk1-ko mice, tbk1-flox mice44 were crossed with cd4-cre transgenic mice (b6 genetic background, jackson laboratories), producing tbk1+/+cd4-cre (named wt) and tbk1fl/flcd4-cre (named tbk1-tko mice) mice. tbk1-flox mice were also crossed with rosa26-cre-er mice (b6 genetic background, jackson laboratories) and the progeny tbk1+/+rosa26-cre-er and tbk1fl/flrosa26-cre-er mice were injected i.p. with tamoxifen (2 mg per mouse) in corn oil daily for four consecutive days to induce cre function. the tamoxifen-treated tbk1+/+rosa26-cre-er and tbk1fl/flrosa26-cre-er mice were named wt-er and tbk1-er mice, respectively, and used 2 weeks after the treatment. carma1-ko mice (b6 × 129 genetic background) were provided by dr josef m. penninger (austrian academy of sciences)46. mice with loxp-flanked allele encoding ikkβ (ikk2) or nemo alleles were provided by dr manolis pasparakis (university of cologne)47. these mice were crossed with cd4-cre mice to generate the t-cell-conditional ikkβ ko (ikkβ-tko) and nemo ko (nemo-tko) mice. ikkε-ko, b6.sjl (cd45.1+), c57bl/6, rag1-ko and tcrβ/δ ko mice were from jackson laboratory. experiments were performed with age-matched mice. mice were maintained in a specific pathogen-free facility of the university of texas md anderson cancer center, and all animal experiments were done in accordance with protocols approved by the institutional animal care and use committee of the university of texas md anderson cancer center.",pmc4302769,1,0.1,39,1,39.1
ship-1,protein,,ptpn11,uniprot,q92533,plasma membrane,go:0005886,jurkat t cells,cell,,,,,,,positive,d,phosphorylation,,jurkat t cells,t-cell,,human,['43'],nan,nan,"(a) naturally ship-1-deficient jurkat t cells were transfected with ship-1 cdna (10 μg). 24h post-transfection, sds wcls were analyzed by wb(n = 4). (b) jurkat t cells pre-treated with pi3k inhibitor (ly-294002, 50 μm) or control inactive enantiomer (ly-303511, 50 μm) for 90 min were stimulated with αcd3 (2 μg/ml) for the indicated times. sds wcls were analyzed by wb (n = 3). (c) jurkat t cells were treated with rapamycin or ku-0063794 (100 nm) for 0, 2, 4, or 6h. sds wcls were analyzed by wb (n = 3). (d) jurkat t cells were transfected with raptor/rptor, pak1, both, or control sirnas (200 μm). 48h post-transfection, sds wcls were analyzed by wb (n = 3). (e) jurkat t cells were first starved (0.5% fcs) for 16h then pre-treated for 2h with cycloheximide (chx, 50 μg/ml). after a 2h chx pre-treatment, cells were not washed and rapamycin (100 nm) was added to the media. every hour sds wcls were made. samples were analyzed by wb. quantitation of a representative wb is shown (n = 3). the wb can be found in (b) of s4 fig. (f) jurkat t cells were transfected with pak1 or control sirnas (200 μm). 48h post-transfection, cells were treated with rapamycin or ku-0063794 (100 nm, 2h). sds wcls were analyzed by wb (n = 4). (g) jurkat t cells were transfected with foxo3, bim or control sirnas (200 nm). after 36h, cells were treated with rapamycin (100 nm, 16h) and lysed. lysates (75%) were subjected to an active caspase 9 ip and the 25% remaining lysates were used to make wcls. samples were analyzed by wb (n = 3).",pmc4487994,1,0.1,39,1,39.1
tbk1,protein,,tbk1,uniprot,p00846,plasma membrane,go:0005886,t cells,other,,,fplx,t cells,plasma membrane,go:0005886,negative,d,regulation,,,b-cell,,mouse,['7'],nan,nan,"in the present study, we employed a conditional tbk1-ko approach and demonstrated an unexpected role for tbk1 in the regulation of t-cell function and autoimmunity. t-cell-specific ablation of tbk1 perturbed t-cell homeostasis, characterized by an increased frequency of t cells with an activated phenotype, and rendered naïve t cells more sensitive to activation by agonistic antibodies for tcr and cd28. surprisingly, the t-cell-conditional tbk1-ko (hereafter called tbk1-tko) mice were refractory to the induction of eae due to impaired migration of autoimmune t cells from the draining lymph nodes to the cns. our data suggest that tbk1 mediates egress of effector t cells from draining lymph nodes in a mechanism that involves negative regulation of the kinases akt and mtorc1.",pmc4302769,1,0.1,39,1,39.1
tbk1,protein,,tbk1,uniprot,q96737,plasma membrane,go:0005886,cd4+ t cells,protein,,cd4a,uniprot,q02367,plasma membrane,go:0005886,negative,d,inhibition,,,b-cell,,vein,['10'],nan,nan,"the data described above not only revealed a previously unknown signalling mechanism regulating t-cell function and cns inflammation but also implicated tbk1 as an attractive therapeutic target for the treatment of ms. to further assess the therapeutic value of tbk1, we tested the effect of tbk1 pharmacological inhibition on the induction of eae. in this regard, a recent study identified the food and drug administration-approved therapeutic compound amlexanox as a selective inhibitor of tbk1 (ref. 36). we asked whether amlexanox could ameliorate eae and, if so, whether it acted through modulating t-cell migration into the cns. we treated the mice daily with amlexanox (via intraperitoneal (i.p.) injection) during the induction of eae. the amlexanox treatment drastically delayed the onset, and reduced the severity, of the eae disease (fig. 6a), which was associated with a profound reduction in the number of cd4+ and cd8+ t cells in the cns of the eae-induced mice (fig. 6b). as seen with the tbk1 gene ablation, the amlexanox treatment did not inhibit t-cell expansion but rather caused the sequestration of t cells in the draining lymph nodes and spleen (fig. 6c). moreover, the t cells isolated from the amlexanox-treated mice displayed aberrant activation of akt and its target protein foxo1 as well as the mtocr1 pathway component s6 (fig. 6d).",pmc4302769,1,0.1,39,1,39.1
tbk1,protein,,tbk1,uniprot,q96x79,cytoplasm,go:0005886,t cells,cell,,,,t cells,immune system,go:0005886,positive,d,expression,gfp,,t-cell,,mouse,['8'],nan,nan,"tbk1-tko bone marrows into lethally irradiated rag1-ko mice and induced eae in the recipient mice. on the basis of gfp expression, we analysed the frequency of wt and tbk1-tko t cells in the cns and draining lymph nodes of the recipient mice during the early effector phase (day 14) of eae induction. within the same recipient mice, the wt t cells (gfp+) efficiently migrated to the cns, whereas the majority of the tbk1-tko t cells (gfp–) were retained in the draining lymph nodes (fig. 4b). since the wt and tbk1-deficient t cells were activated under the same conditions, these results suggest that the defect of the tbk1-deficient t cells in infiltrating into cns is not due to attenuated cns inflammation but rather due to a cell-intrinsic deficiency.",pmc4302769,1,0.1,39,1,39.1
pd-l1,protein,,pdcd1l1,uniprot,q15227,plasma membrane,go:0005886,treg cells,celltype,,tcrv1,,treg cells,,,negative,d,binds,,hiv-infected individuals,cd4+ t cells,,human,['49'],nan,nan,the proliferative capacity of treg cells and cd8 t cells from hiv-infected individuals is differentially restored by pd-l1 blockade and depends on the plasma viremia of the host,pmc4669187,1,0.1,39,1,39.1
tcr,other,,,fplx,tcr,plasma membrane,go:0005886,il-2,cytokine,,il2,uniprot,q02302,cytoplasm,go:0005634,positive,d,phosphorylation,,,b-cell,,vein,['4'],nan,nan,"indeed, although tcr and il-2 signaling are often evaluated independently, both activate several similar downstream readouts. moreover, several lines of data indicate that tcr signaling can influence il-2 signaling. although tcr signaling up-regulates cd25, which is required for il-2 responses in mouse t cells, high tcr engagement paradoxically decreases stat5 phosphorylation so that more efficient stat5 phosphorylation occurs with low tcr engagement (lee et al., 1999; yamane and paul, 2013). nonetheless, although stat5 is often used as a surrogate for il2 responses, stat5 activation is only one of multiple pathways activated by il-2 (liao et al., 2013). our results suggest that tcr signaling can differentially affect the activation of pathways downstream of il-2 and demonstrate that at least one way this is accomplished is through modulating expression of pten, thereby uncoupling stat5 and pi3k activation. whether altered pten regulation contributes to the influence of itk and tcr signaling on responses to other cytokines and pathways of differentiation remains to be evaluated. in cd8+ t cells, activation of akt and mtor pathways has been closely linked to regulation of cell trafficking, in part through effects on expression of homing receptors (finlay and cantrell, 2011; finlay et al., 2012). although we have not directly explored these pathways, decreased cd4+ t cell numbers have been observed in the lungs of itk-deficient mice in models of allergic asthma (ferrara et al., 2006). it is intriguing to speculate that migration of effector cells may also be influenced in itk-deficient mice by virtue of alterations in phospholipid metabolism. furthermore, these effects are not limited to those influenced by akt and mtor, as pi(3,4,5)p3 is involved in the activation of multiple ph domain–containing proteins, including itk itself and other t cell signaling molecules.",pmc3949578,1,0.1,39,1,39.1
tcr,other,,,fplx,tcr,plasma membrane,go:0005886,lat,protein,adapter,lat,uniprot,q92530,plasma membrane,go:0005886,positive,d,phosphorylation,"y132, y136",,b-cell,,vein,['39'],nan,nan,"engagement of the t cell antigen receptor (tcr) initiates a number of downstream signaling pathways resulting in t cell activation and proliferation. these activation events enable helper (cd4+) t cells to produce cytokines and activate other immune cells resulting in a functional adaptive immune response. one immediate result of tcr activation is the tyrosine phosphorylation of many signaling proteins in cd4+ t cells. a protein that is heavily phosphorylated on tyrosine following tcr stimulation is the adapter protein lat (linker for activation of t cells). upon tcr stimulation, lat is phosphorylated on multiple tyrosines, one of which (y132 in human lat, y136 in mouse lat) then acts as a docking site for the phospholipase plc-γ1. other lat tyrosines act as docking sites for numerous other signaling molecules (see[1]). previously we and others generated knock-in mice that express lat with y136 mutated to f136, hereafter referred to as lat-ki mice [2, 3]. these mice have an early block in t cell maturation but later develop a lymphoproliferative disease characterized by marked splenomegaly and lymphadenopathy. the disease is dependent on lat mutant t cells [4] and the mice show a hyper-proliferation of cd4+ helper t cells that secrete large amounts of the signature th2 cytokine, il-4 [2, 3].",pmc4487994,1,0.1,39,1,39.1
zap70,protein,,zap70,uniprot,p16485,plasma membrane,go:0005886,tcr,other,,,fplx,tcr,plasma membrane,go:0005886,negative,d,phosphorylation,,,b-cell,,vein,['33'],nan,nan,"finally, tcr-dependent zap70 phosphorylation was not different between cd5-δck2bd and cd5-wt newborn mice (fig 7g). this result indicates that tcr proximal signals in newborn mice and adult mice (fig 6b) do not contribute to the enhanced mapk activation observed in cd5-δck2bd thymocytes.",pmc5193405,1,0.1,39,1,39.1
zstk-474,drug,small molecule inhibitor,stk474,uniprot,q8wvt7,plasma membrane,go:0005886,lat,protein,,lat,uniprot,p01730,plasma membrane,go:0005886,negative,d,inhibition,,loucy,b-cell,,human,['24'],nan,nan,"annexin v-fitc/pi analysis confirmed a significant increase in apoptotic cells following treatment with zstk-474 for 48 h in all the cell lines, whereas dual p110γ/δ inhibition had limited effects, inducing a significant cell death only in the loucy cell line (fig. 5b).",pmc4496363,1,0.1,39,1,39.1
pd-l1,protein,,pdcd1l1,uniprot,q15233,plasma membrane,go:0005886,treg cells,cell,,,,,,,positive,d,production,,,treg cells,,human,['51'],nan,nan,"upon pd-l1 blockade, the fold change of treg cell proliferation was the highest in viremic individuals and correlated with viral loads. however the fold change of treg cell proliferation was not significantly correlated with pd-1 expression itself although pd-1 expression was correlated to viral loads. thus there might be additional factors that have participated in the observed gain in proliferation. one good candidate for this is il-2 that is produced upon t cell stimulation but may have been limiting with increasing pd-1 expression and negative signalling on cd4 t cells, the main il-2 producers. consistent with this are previous observations that (i) the pd-1/pd-l1 pathway negatively regulates treg cell proliferation by inhibiting the il-2 signalling cascade [34] and (ii) exogenous il-2 can overcome pd-1/pd-l1-mediated inhibition of proliferation [53].",pmc4669187,1,0.1,39,1,39.1
pakt (s473),protein,,akt1,uniprot,q04957,plasma membrane,go:0005886,,,,,,,,,,i,,,,,,,['57'],nan,nan,nan,nan,1,0.1,39,1,39.1
pd-l1,protein,,pdcd1l1,uniprot,q07817,plasma membrane,go:0005886,cd8-,protein,,cd8a,uniprot,p01730,plasma membrane,go:0005886,positive,d,binds,,,t-cell,,human,['53'],nan,nan,"impact of pd-l1 blockade for treg, cd4- and cd8- t cells.",pmc4669187,1,0.1,39,1,39.1
pd-1,protein,,pdcd1,uniprot,q15242,plasma membrane,go:0005886,treg cells,cell,,tcrg1,uniprot,treg cells,immune system,go:0005634,negative,d,binds,,,t-cell,,human,['48'],nan,nan,pd-1 expression on treg cells is associated with disease progression,pmc4669187,1,0.1,39,1,39.1
bcl-xl,protein,,bcl2l1,uniprot,q07817,mitochondria,go:0005739,apaf-1,protein,,apaf1,uniprot,o14727,mitochondria,go:0005739,negative,d,binds,,hek 293t,epithelial-like,kidney,human,['28'],nan,nan,"pten's tumor suppressor function is usually abrogated following mutations in its phosphatase domain, which is encoded by exon 5 [23] (figure 1). these mutations typically include a c124s mutation that abrogates both lipid and protein phosphatase activity and a g129e mutation that abrogates lipid phosphatase but not protein phosphatase activity [24]. although the n-terminal phosphatase domain is principally responsible for pten's physiological activity, approximately 40% of tumorigenic pten mutations occur in the c-terminal c2 domain (corresponding to exons 6, 7, and 8) and in the tail sequence (corresponding to exon 9), which encode for tyrosine kinase phosphorylation sites. this suggests that the c-terminal sequence is critical for maintaining pten function and protein stability [21, 23, 25, 26]. however, many tumor-derived pten mutants retain partial or complete catalytic function, suggesting that alterative mechanisms can lead to pten inactivation.",pmc4712330,1,0.1,39,1,39.1
cd4+ t cells,cell,,cd4,uniprot,p01730,plasma membrane,go:0005886,t cells,cell,,,uniprot,t cells,plasma membrane,go:0005886,negative,d,phosphorylation,,,b-cell,,vein,['5'],nan,nan,"cd4+ t cells were purified by negative selection using a magnetic cell separation system according to the manufacturer’s protocol (miltenyi biotec). naive (cd4+cd44lowcd62lhighcd25− t cells) or foxp3+ treg (cd4+ foxp3gfp-high) cells were purified by cell sorting at a purity >99%. cells were cultured in complete rpmi 1640 media as indicated in gomez-rodriguez et al. (2009). in brief, sorted naive cd4+ t cells (2 × 105) were co-cultured at a ratio of 1:5 with mitomycin-treated t-depleted splenocytes as apcs for the indicated amount of time in 48-well plates containing 1 µg/ml anti-cd3 (2c11) plus 3 µm/ml anti-cd28 (bio x cell) or as indicated in the figure legends under different conditions. th17 cells: 20 ng/ml il-6, 5 ng/ml tgf-β1, and 10 µg/ml of each anti–il-4, anti–ifn-γ, and anti–il-12 antibodies. treg cells: 100 u/ml hil2, 5 ng/ml tgf-β1 with 0.1, 1, or 5 µg anti-cd3, and 10 µg/ml of each anti–il-4, anti–ifn-γ, and anti–il-12 antibodies. treg cells + anti-cd28 condition: 100 u/ml hil2, 5 ng/ml tgf-β1 with 1 µg/ml anti-cd3 plus 3 µg/ml anti-cd28, and 10 µg/ml of each anti–il-4, anti–ifn-γ, and anti–il-12 antibodies. th-null conditions: 1 µg/ml anti-cd3 plus 3 µm/ml anti-cd28 and 10 µg/ml of each anti–il-4, anti–ifn-γ, and anti–il-12 antibodies. cytokines were purchased from peprotech. cytokine antibodies were purchased from bio x cell. for inhibition experiments, sorted naive cd4+ t wt cells and apcs were incubated with the inhibitor ly29400 (sigma-aldrich) for 40 min before stimulation with the indicated differentiation conditions for 48 h. naive cd4 t cells from 5cc7 transgenic mice were cultured as indicated before except that pcc peptide was used instead of anti-cd3. for evaluating responses to il2, sorted naive cd4+ t cells from wt and itk−/− mice were stimulated under th17, treg, or th-null conditions, in the presence of apcs for 2 d in the absence or presence of 10 µg/ml of blocking anti-il2 or anti-il2 plus the indicated amount of hil2 (100 u/ml). alternatively, sorted naive cd4+ t cells from wt and itk−/− mice were activated for 2 d in the presence of apcs plus 1 µg/ml anti-cd3, 3 µg/ml anti-cd28, and 10 µg/ml of each anti-il12, anti-il4, and anti–ifn-γ. under these conditions, foxp3+ cells were not generated. cells were starved for 3 h and then stimulated with hil2 for different time points to evaluate ps6 and pstat5.",pmc3949578,1,0.1,39,1,39.1
cd4+ t cells,cell,,tcr,uniprot,tcr,plasma membrane,go:0005886,akt1/2,protein,,akt1,uniprot,q17273,plasma membrane,go:0005886,positive,d,inhibitor,,naïve cd4 t cells,b-cell,,human,['13'],nan,nan,"cd4+ t cells were purified from splenocytes with anti-cd4-conjugated magnetic beads (invitrogen). inhibitor studies were carried out by culturing the cells in 24-well plates (4 × 106 cells per well) in the presence of akt1/2 inhibitor (akti, 1 μm), the pi3 kinase inhibitor (ly294002, 50 μm) or the tbk1 inhibitor (mrt67307, 2 μm). for elisa and proliferation assays, naïve cd4 t cells were stimulated in replicate wells of 96-well plates (1 × 105 cells per well). culture supernatants were analysed by elisa (ebioscience), and cells were pulse-labelled for 6 h with [3h]thymidine for proliferation assays.",pmc4302769,1,0.1,39,1,39.1
cd4-,protein,,,uniprot,p01730,plasma membrane,go:0005886,tcr,other,,,fplx,tcr,plasma membrane,go:0005886,positive,d,phosphorylation,,,b-cell,,vein,['20'],nan,nan,"cells were cultured with increasing concentrations of the drugs for 48 h followed by metabolic activity assessment by mtt assay (fig. 1a and 1c). in both pten deleted (jurkat and loucy) and pten non deleted (dnd-41 and all-sil) cells, growth rate decreased after treatment with bkm-120 and zstk-474 with ic50 values ranging between 1.05–2.34 μm for bkm-120 and 0.99–3.39 μm for zstk-474. conversely, pik-90 only mildly affected t-all cell line viability, with the exception of loucy cells (ic50 0.096 μm). as expected, selective inhibition of p110α, p110β, p110γ, and p110δ isoforms resulted ineffective, with ic50 values not attained at the tested concentrations. we further investigated the effectiveness of combining p110δ and p110γ inhibitors, by treating t-all cell lines with cal-101 and as-605240 at a fixed ratio (1:1). as shown in fig. 1b and 1d, the inhibitors resulted in a strong (ci < 0.3) to moderate (ci < 0.9) synergism in all-sil, loucy, and jurkat cells at concentrations above 1 μm, whereas in dnd-41 cells the drug combination did not exert a synergistic but rather an antagonistic (at 1 and 2 μm) or additive (at 4 and 8 μm) effect. nevertheless, ic50 values achieved by the combined treatment were much higher compared to those of pan-inhibitors (fig. 1c). interestingly, the dual p110γ/δ inhibitor ipi-145 was effective only in loucy cells. overall, pi3k isoform pan-inhibition was much more efficient in affecting t-all cell viability when compared to specific as well as dual p110γ/δ inhibition. based on these results, we selected zstk-474 as pan-inhibitor and we used the concentration of 5 μm for the following experiments to simplify comparison of the results obtained with the other inhibitors.",pmc4496363,1,0.1,39,1,39.1
cd5,protein,,cd5,uniprot,p00746,plasma membrane,go:0005886,tcr,other,,,fplx,tcr,plasma membrane,go:0005886,positive,d,phosphorylation,,,b-cell,,vein,['32'],nan,nan,"within cd4+sp thymocytes, high tcr avidity selects for ntreg cells and this population is expanded in mice lacking cd5 [9]. in peripheral t cells, cd5-ck2 signaling modulates akt activity [11], a signaling pathway down regulated during the generation of ntreg [17, 18]. we observed no difference in frequency or numbers of ntreg cells (cd4+cd25+foxp3+) between cd5-ck2δbd and cd5 wt mice (fig 3a and 3b). this result suggests that the cd5-ck2 signaling axis is not involved ntreg selection in the thymus and therefore is not responsible for the increased cd4:cd8 ratio observed in cd5-ck2δbd mice; however, other domains within the cytoplasmic tail of cd5 shown to regulate tcr signaling, such as the itim (y429-441) domain or the carboxy-terminal y463, may regulate ntreg generation.",pmc5193405,1,0.1,39,1,39.1
cd5,protein,,cd5,uniprot,p01730,plasma membrane,go:0005886,tcr,other,,,fplx,tcr,plasma membrane,go:0005886,positive,d,phosphorylation,,,b-cell,,vein,['34'],nan,nan,"cd5 expression strongly correlates with the strength of tcr signaling [6]. interestingly, the lack of cd5-ck2 signaling had no effect on expression of cd5 on any thymic subpopulation thus, tcr-induced cd5 upregulation is likely to be regulated by other cd5 cytoplasmic regions, like the cd5-itim domain [7]. the elevated basal perk observed in adult mice led us to predict that ntreg numbers would be expanded in cd5-δck2bd thymus, as we previously showed in cd5-/- mice [9]. several tcr proximal downstream effector are required for optimal ntreg generation, including plcγ1 [41], lat [42], arguing in favor of the need of a strong signal threshold for their selection (reviewed in [43]). however, we found no expansion of ntreg cells in the absence of cd5-ck2 signaling indicating that other than erk, proximal tcr signals, unaffected in cd5-δck2bd mice, are involved in ntreg generation. additionally, inhibition of the akt/mtor axis is required during ntreg selection [17], which was unaltered in cd5-δck2bd mice. finally, although ck2 is highly expressed in ntregs compared to effector t cells, our results show that ck2 associated with cd5 is not relevant for ntreg selection [44].",pmc5193405,1,0.1,39,1,39.1
hif1α,protein,,hif1a,uniprot,p05834,cytoplasm,go:0005739,hif1α,protein,,hif1a,uniprot,p05834,cytoplasm,go:0005739,positive,d,expression,,cd4+ t cells,t cell,,mouse,['3'],nan,nan,"among the critical pathways controlled by mtor is the regulation of cellular metabolism. indeed, in recent years there has been an increasing recognition of how metabolism contributes to/helps control t cell fate and the role of mtor in this process. a critical element of this process is the expression of the transcription factor hif1α; cd4+ t cells deficient in hif1α exhibit increased foxp3 and reduced il17a under th17-inducing conditions (dang et al., 2011; shi et al., 2011). hif1α-deficient cd4+ t cells also show increased responsiveness to foxp3-inducing cytokines, similar to our observations in itk-deficient cells (dang et al., 2011). nonetheless, how tcr signaling contributes to this regulatory axis is not well appreciated. our results suggest that itk and tcr signaling play a critical role in regulating the expression of hif1α by functioning as a rheostat that determines the extent of activation of pi3k- and mtor-activated pathways. at least part of this occurs through effects on the expression of pten. we further show that pten expression is tightly regulated by tcr signaling, with strong tcr signals leading to a marked repression of pten message, supporting previous work from bensinger et al. (2004). this repression is defective in itk-deficient cells, even under conditions in which wt and itk−/− cd4+ t cells develop equivalent percentages of foxp3+ itreg cells, suggesting that these observations are not secondary to altered differentiation. furthermore, treatment of itk-deficient cd4+ cells with pten-specific shrna reduced the generation of foxp3+ cells, supporting the idea that altered pten expression contributes to rather than results from the increased generation of foxp3+ cells. indeed, under conditions of strong tcr signals, where we see decreased expression of pten, we see reciprocal regulation and increased ps6 and elevated expression of the mtor target gene, hif1α. our results suggest that by altering the expression of pten, impaired tcr signaling can affect the activation of signaling pathways downstream of multiple receptors, supporting the idea that tcr signaling controls the ability of t cells to integrate diverse inputs. this regulation provides a distinct positive feedback mechanism by which pi3k-mediated pathways can be exquisitely controlled to affect effector cell differentiation.",pmc3949578,1,0.1,39,1,39.1
il2-inducible t cell kinase (itk),protein,,itk,uniprot,q96lb7,plasma membrane,go:0005886,tcr,other,,,fplx,tcr,plasma membrane,go:0005886,positive,d,phosphorylation,,,b-cell,,vein,['1'],nan,nan,"il2-inducible t cell kinase (itk) belongs to the tec family of tyrosine kinases and is an important component of tcr-mediated signaling (berg et al., 2005). in contrast to other more proximal molecules, loss of itk does not prevent tcr signaling. instead, the absence of itk leads to impaired tcr signaling associated with decreased activation of plc-γ and the downstream pathways involved in ca2+ mobilization, ras and extracellular signal-regulated kinase (erk) cascades, and regulation of the actin cytoskeleton. accordingly, mutation of itk has been shown to both impair and alter t cell functional outcomes (berg et al., 2005; gomez-rodriguez et al., 2011). we have previously shown that itk is a positive modulator of il17a production, with reduced percentages of il17a-producing cells in itk-deficient cd4+ t cells generated under th17 conditions (gomez-rodriguez et al., 2009). how itk affects treg cell generation and its effects on the metabolic control of differentiation have not been explored.",pmc3949578,1,0.1,39,1,39.1
itk,protein,tec family kinase,itk,uniprot,q96x77,plasma membrane,go:0005886,tcr,other,t cell receptor,,fplx,tcr,plasma membrane,go:0005886,positive,d,phosphorylation,,cd4+ t cells,t cell,,mouse,['0'],nan,nan,"a proper balance between th17 and t regulatory cells (treg cells) is critical for generating protective immune responses while minimizing autoimmunity. we show that the tec family kinase itk (il2-inducible t cell kinase), a component of t cell receptor (tcr) signaling pathways, influences this balance by regulating cross talk between tcr and cytokine signaling. under both th17 and treg cell differentiation conditions, itk−/− cd4+ t cells develop higher percentages of functional foxp3+ cells, associated with increased sensitivity to il-2. itk−/− cd4+ t cells also preferentially develop into treg cells in vivo. we find that itk-deficient t cells exhibit reduced tcr-induced phosphorylation of mammalian target of rapamycin (mtor) targets, accompanied by downstream metabolic alterations. surprisingly, itk−/− cells also exhibit reduced il-2–induced mtor activation, despite increased stat5 phosphorylation. we demonstrate that in wild-type cd4+ t cells, tcr stimulation leads to a dose-dependent repression of pten. however, at low tcr stimulation or in the absence of itk, pten is not effectively repressed, thereby uncoupling stat5 phosphorylation and phosphoinositide-3-kinase (pi3k) pathways. moreover, itk-deficient cd4+ t cells show impaired tcr-mediated induction of myc and mir-19b, known repressors of pten. our results demonstrate that itk helps orchestrate positive feedback loops integrating multiple t cell signaling pathways, suggesting itk as a potential target for altering the balance between th17 and treg cells.",pmc3949578,1,0.1,39,1,39.1
lat,protein,,lat,uniprot,q15642,plasma membrane,go:0005886,tcr,other,,,fplx,tcr,plasma membrane,go:0005886,positive,d,phosphorylation,,,t-cell,,human,['40'],nan,nan,"we have been interested in determining what known and novel pathways of t cell signaling drive lat-ki t cell proliferation. in classical tcr signaling pathways in normal t cells, tcr activation results in protein tyrosine kinase activation, lat phosphorylation, and plc-γ1 recruitment and activation. plc-γ1 converts pip3 to ip3 and dag. increases in ip3 levels lead to calcium influx. increases in dag levels lead to activation of pkcs and rasgrp, a rasgef that activates ras, which leads to the activation of erk [1]. in lat-ki peripheral t cells, tcr-induced calcium influx was absent, as predicted from the loss of plc-γ1 activity. unexpectedly, erk activation was observed in lat-ki t cells [5].",pmc4487994,1,0.1,39,1,39.1
luciferase,protein,,,uniprot,,cytoplasm,go:0005886,pc3m-luc,cellline,,,uniprot,,cytoplasm,go:0005886,negative,d,binds,,pc3m-luc,adenocarcinoma,,human,['16'],nan,nan,"luciferase expressing cell line pc3m-luc was established by transducing pc3m with retroviruses encoding luciferase and selection with g418. to examine the cytotoxicity of pbls transduced with different retroviruses, pc3m-luc cells were incubated with effector cells for 24 h, and then luciferin (promega) was added at a final concentration of 0.3 mg/ml. 10 min later, luminescence imaging was conducted on ivis system (xenogen/caliper life sciences).",pmc4550078,1,0.1,39,1,39.1
mek1,protein,,mapk8,uniprot,p00768,cytoplasm,go:0005634,mefs,cell,,,,,cytoplasm,go:0005634,positive,d,phosphorylation,,mefs,fibroblast-like,,mouse,['56'],nan,nan,"mefs and stable ko clones re-expressing wt and mutant mek1 (catalanotti et al., 2009) were grown in dulbecco’s modified eagle’s medium plus 10% (v/v) fetal calf serum (fcs) (paa) and starved in 0.5% (v/v) fcs overnight prior to treatment with egf (2 ng/ml, biomedical technologies). inhibitors (10 nm pd0325901, sigma-aldrich; 10 μm u0126 and 50 μm ly294002, cell signaling) were added 1 hr before stimulation. mefs were transfected with 30 nm magi sirna duplexes (sakurai et al., 2006) or nontargeting pool (d-001810-10-05, dharmacon) with lipofectamine rnaimax (invitrogen). cos-7 cells were transfected with turbofect (fermentas).",pmc3625979,1,0.1,39,1,39.1
microrna,other,,,uniprot,mirna,cytoplasm,go:0005634,u6 microrna,other,,malat1,uniprot,q9hza2,cytoplasm,go:0005634,negative,d,binds,,,,,human,['6'],nan,nan,microrna was isolated using the mirvana isolation kit (life technologies) according to the manufacturer’s recommendations. rna was converted into cdna using specific microrna primers with the taqman microrna reverse transcription kit (life technologies). qrt-pcr was performed using the taqman assay with specific microrna primers (life technologies). to determine relative expression levels samples were normalized to u6 microrna using the 2−δδct method and abi 7500 sds 1.3.1 software.,pmc3949578,1,0.1,39,1,39.1
mir-155,microrna,,mir155,uniprot,q06037,cytoplasm,go:0005739,b cells,cell,,bcel,uniprot,q05830,cytoplasm,go:0005739,negative,d,inhibition,,,b-cell,,mouse,['47'],nan,nan,"mir-155 overexpression has been correlated with various types of cancers, including lymphomas [10, 11]. forced overexpression of mir-155 in b cells in mice led to the development of b cell lymphomas [65]. in contrast, nanoparticle delivery of anti-mir-155 nucleic acids led to the regression of the lymphomas in those mice. therefore in those studies and in our study, depletion of mir-155 levels resulted in less disease, i.e. lymphoma or lymphoproliferative disease, as defined by regression or prevention of disease, respectively. however, in the study of babar et al. just mentioned above, the disease being “cured” was initiated solely by mir-155 overexpression whereas lat-ki disease results from lat mutation and downstream mir-155 overexpression, presumably in addition to many other alterations in gene expression. collectively, these studies point to a critical role for mir-155 in some lymphoproliferative diseases and lymphomas.",pmc4487994,1,0.1,39,1,39.1
mir-155,smallrna,mirna,mir155,mirbase,mir155,cytoplasm,go:0005634,bim,protein,,bcl2l11,uniprot,q96xa7,mitochondria,go:0005739,positive,d,binds,,,t-cell,,mouse,['41'],nan,nan,"in this study we show that lat-ki lymphoproliferative disease is highly dependent on mir-155. bim-mediated apoptosis was enhanced in lat-ki t cells upon mir-155 deletion and less lymphoproliferative disease was observed in lat-ki mir-155 null double mutant mice. we used lat-ki mice to define t cell signaling pathways, this time downstream from mir-155. multiple pathways mediated mir-155 regulation of bim-mediated apoptosis in lat-ki t cells. foxo3 activity was influenced directly by mir-155 and indirectly through ship-1 and akt. foxo3 activity was also controlled by pak1 and jnk. pak1 activity was regulated by mtor, downstream of ship-1 and akt, with mtor bridging the ship-1/akt and pak1/jnk pathways. we discuss how mir-155 can affect the balance between the pro-apoptotic pak/jnk/foxo3/bim pathway and the pro-proliferative pak1/raf/mek/erk pathway to control t cell expansion and death resulting in the regulation of lymphoid organ size and function.",pmc4487994,1,0.1,39,1,39.1
mir-155,smallrna,mirna,mir155,mirbase,mir155,cytoplasm,go:0005634,ship-1,protein,,ptpn11,uniprot,p00712,plasma membrane,go:0005886,positive,d,binds,,,t-cell,,mouse,['44'],nan,nan,"to summarize our results, mir-155 acts through its direct targets ship-1 and foxo3. foxo3 nuclear translocation and activation occurs via two pathways, ship-1/akt and pak1/jnk. mtor provides crosstalk between these two pathways. downstream of foxo3 activation, bim/bcl2l11 expression is increased and bim-mediated apoptosis ensues. we propose that mir-155 deletion in lat-ki mice causes a decrease in lymphoproliferative disease based on this increased bim-mediated apoptosis. to test the importance of these pathways, which both funnel through bim, we crossed dm mice with bim-deficient mice. as shown in fig 8a and s5 fig, bim deficiency largely restored lymphoproliferative disease in dm mice, providing evidence for the importance of bim in lymphoproliferative disease in the lat-ki background. a summary of the interacting pathways thought to be impacted by mir155 deletion in cd4+ t cells is presented in fig 8b.",pmc4487994,1,0.1,39,1,39.1
mir-155,smallrna,mirna,mir155,mirbase,mir155,cytoplasm,go:0005739,bim,protein,,bcl2l11,uniprot,o14727,cytoplasm,go:0005739,positive,d,binds,,,t-cell,,mouse,['45'],nan,nan,"our data suggest that mir-155 affects the balance between proliferation and apoptosis in t cells. because we hypothesized that the contribution of mir-155 expression to apoptosis was key to controlling lymphoproliferative disease in lat-ki mice, we extensively studied molecular mechanisms leading to apoptosis in lat-ki and dm t cells. levels of apoptosis in dm compared to lat-ki t cells were higher as measured by increased annexinv staining and levels of active caspase3, active caspase9, and parp. we also found elevated levels of the pro-apoptotic factor bim in dm compared to lat-ki t cells. there is ample evidence for the pro-apoptotic functions of bim [27, 28, 48] and it has been reported that foxo3 directly induces the transcription of bim/bcl2l11 [14, 30–32]. because the transcription factor foxo3 is a direct target of mir-155, mir-155 can directly regulate its expression and thus that of bim [16, 17]. foxo3, bim, and phospho-bim levels were higher in dm than in lat-ki t cells. in addition to direct regulation, we defined several linked pathways downstream of mir-155 in t cells that converge to regulate the nuclear translocation and activation of foxo3 (fig 8). recently it has been suggested that foxo3 could play an indirect role in bim mrna regulation possibly via other transcription factors or mirnas [49]. regardless of the mechanism, we propose that differing levels of foxo3-initiated, bim-mediated apoptosis lead to different amounts of lymphoproliferative disease in lat-ki mice.",pmc4487994,1,0.1,39,1,39.1
pd-1,protein,,pdcd1,uniprot,q05209,plasma membrane,go:0005886,treg cells,cellpopulation,,,,treg cells,,,positive,d,phosphorylation,,,t-cell,,human,['50'],nan,nan,"the direct correlation of pd-1 on treg cells with patient’s viral load is consistent with the idea that persistent antigen exposure is a main trigger of pd-1 expression. however, exposure of pbmcs to hiv under non-stimulating conditions did not induce pd-1 on effector or on resting treg cells significantly thus suggesting that additional activation signals are required. interestingly, this exposure to hiv was sufficient to massively up-regulate pd-l1 on both etreg and rtreg cells in a virus dose-dependent manner. as pd-l1 can participate in treg cell induction [26–28] as well as pd-1-mediated suppression [29,30,32], the role of both treg cell states in virus sensing and subsequent signal conversion merits further investigation.",pmc4669187,1,0.1,39,1,39.1
zstk-474,smallmolecule,inhibitor,,uniprot,,plasma membrane,go:0005886,cell cycle,cellularprocess,,,uniprot,,plasma membrane,go:0005886,positive,d,inhibition,,"all-sil, jurkat, loucy","b-cell, t-cell",,human,['23'],nan,nan,"since pi3k/akt signaling controls different cellular pathways, we examined the inhibitor effects on cell cycle and induction of apoptosis. interestingly, cell cycle was affected in all the cell lines following pan-inhibition (zstk-474 treatment for 48 h) (fig. 5a). flow cytometric analysis documented an accumulation of cells in the g0/g1 phase of the cell cycle and a consequent decrease of cells in the s or g2/m phases, as previously reported [23], which reached a statistical significance in all-sil and dnd-41 cells. moreover, in jurkat, loucy, and all-sil cells, zstk-474 increased the subg1 cell fraction, which comprises death cells. less dramatic effects were observed with the other inhibitors, which affected only all-sil and loucy cells. in particular, the combination of as-605240 and cal-101 altered cell cycle phase distribution in loucy cells, by increasing the g0/g1 fraction. however, the dual γ/δ inhibitor ipi-145 had no effects.",pmc4496363,1,0.1,39,1,39.1
pten,protein,,pten,uniprot,q96630,plasma membrane,go:0005886,pdk1,protein,,pdk1,uniprot,q96631,plasma membrane,go:0005886,negative,d,inhibits,,,b-cell,,mouse,['26'],nan,nan,"a recent study in which ptenfl/fl × cd4-cre mice were crossed to pdk1fl/fl mice has shown that while lymphoma did not develop in this model of t cell-specific pten deletion, pdk1/akt signaling was dispensable for the survival, proliferation and differentiation of t cell progenitors, and in vivo expansion of peripheral t cells (finlay et al., 2009). the mechanism for control of cell metabolism independent of pdk1 is unclear in these mice, although thymocyte proliferation in the absence of pten was shown to require rhoa-dependent pathways, and a dependence on c-myc, which was recently shown to play a pivotal role in t cell metabolism following activation (wang et al., 2011), was not ruled out. mice which express a single hypomorphic pdk1 allele similarly prevented a wide range of tumors when crossed to pten heterozygous mice, indicating that the requirement for pdk1 in the context of tumor formation brought on by loss of pten is not limited to its role in controlling migratory capacity of t cells (bayascas et al., 2005). additionally, deletion of s6k1 in the mx-1-cre model of pten loss resulted in delayed development of leukemia, indicating that an mtorc1-mediated pathway, in this context shown to involve induction of a hif-1α-dependent glycolytic program, contributes to leukemogenesis in pten-deficient cells (tandon et al., 2011).",pmc3375464,1,10,19,1,29
pten,protein,,pten,uniprot,q04127,nucleus,go:0005739,pi3k,protein,,pi3k,uniprot,q04127,nucleus,go:0005739,negative,d,inhibits,,,,,human,['31'],nan,nan,"most of the functions of nuclear pten are independent of its phosphatase activity and do not involve the pi3k/akt pathway. not only pten but also activated pi3k and functional pip3 have been detected in the nucleus [71], indicating that nuclear pi3k signaling mediates pten's antiapoptotic effect through nuclear pip3 and nuclear akt. nevertheless, only limited evidence suggests that nuclear pten has lipid phosphatase functions, as the nuclear pool of pip3 is insensitive to pten [72].",pmc4712330,1,10,19,1,29
pten,protein,,pten,uniprot,p00055,plasma membrane,go:0005886,pi3k,protein,,pi3k,uniprot,q02909,plasma membrane,go:0005886,negative,d,phosphorylation,ser380,jurkat,t-cell,,human,['22'],nan,nan,"firstly, we investigated cell lines with regard to pi3k isoforms and pten expression. as shown in fig. 3a, the catalytic subunits p110α, −β, −γ and −δ were expressed in control as well as treated samples to a similar extent. as expected, pten protein was absent in jurkat and loucy cells, but abundantly expressed and unaffected by drug treatments in all-sil and dnd-41 cells. nevertheless, in both of these cell lines, pten was phosphorylated at ser380, which is a marker of pten posttranslational inactivation by ck2 and consequent pi3k pathway activation [12, 33].",pmc4496363,1,10,19,1,29
